Uploaded August 2026 | Updated September 2026, 2 weeks ago

---

The FDA approved a daily pill called Rasonque, that in clinical trials doubled survival time for many patients compared to chemotherapy alone. NBC’s medical contributor Dr. Natalie Azar joins TODAY to break down how the drug impacts cancer treatment. “This particular medicine is targeting a protein that has eluded scientists for literally decades,” she says.

» Subscribe to TODAY: youtube.com/@TODAY

TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.

Connect with TODAY Online!
Visit TODAY's Website: today.com
Find TODAY on Facebook: facebook.com/today
Follow TODAY on Twitter: twitter.com/TODAYshow
Follow TODAY on Instagram: instagram.com/todayshow

» Stream TODAY All Day: today.com/allday
About: TODAY All Day is a 24/7 streaming channel bringing you the top stories in news and pop culture, celebrity interviews, cooking, and more. All in one place.

#fda #heath #cancer